Clinical Trial Update: A Clinical Endpoint Bioequivalence Study to Assess Efficacy and Safety of Ivermectin 0.5% Lotion in the Treatment of Head Lice [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating efficacy and safety of ivermectin 0.5% lotion for treating head lice has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head Lice

Drugs mentioned

• ivermectin 0.5% lotion (ivermectin)

Snippet

Sponsor: Mayne Pharma International Pty Ltd | Conditions: Head Lice | Phase 3 | Status: COMPLETED | Results posted: 2020-09-17